Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 67   

Articles published

MRK 61.48 -0.86 (-1.38%)
price chart
Pre-Market Movers (AIG, DryShips, Merck, Complete Genomics, SAP, Deutsche Bank ...
Merck & Co Inc. (MRK) stock advanced 2.18 percent to $42.11 in pre-market trading. The company plans to close an advanced clinical study of its osteoporosis drug after an interim analysis showed that the trial met its primary efficacy goals, and that ...
37 African American Students Awarded Prestigious UNCF/MERCK Science Initiave ...
... and 43 percent of the U.S.'s postdoctoral researchers in science, engineering, and health are foreign students. Merck and UNCF began UMSI in 1995 with a ten-year, $20 million grant from the Merck Company Foundation and Merck Research Laboratories.
Should I Buy Merck? 3 Pros, 3 Cons
Merck & Co. (NYSE:MRK) In today's trading, Merck's (NYSE:MRK) shares hit a 52-week high, reaching nearly $45.
Merck & Co and Dashtag plans to acquire 21% stake in Fulford (India) through ...
Merck & Co. Inc. and Dashtag, have decided to acquire 21.07 per cent equity stake (8.22 lakh equity shares) of Fulford (India) through voluntary open offer at a price of Rs 830 per share of Rs.10 each aggregating to Rs.68.22 crore.
QLT and Cardiome both wield the axe
The latest cut was expected after Cardiome's partner, pharmaceutical giant Merck & Co. Inc., said in March it would stop efforts to commercialize Cardiome's oral treatment for irregular heartbeat.
How They Won It: Lowenstein Breaks Ground With Schering Win
Law360, New York (July 10, 2012, 5:23 PM EDT) -- Attorneys for Lowenstein Sandler PC didn't just preserve a win for Schering-Plough Corp.
Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the company has signed two licensing agreements for investigational HIV drug candidates. Additionally, the company ...
Merck osteoporosis drug, company pipeline win more respect
Industry analysts on Thursday predicted annual sales of up to $3 billion for a Merck osteoporosis drug shown to be effective before its clinical trial was completed, and said the development could provide a needed jolt of faith in Merck's overall drugs ...
Bristol Myers Squibb, AstraZeneca Join Forces in $7B Deal for Amylin
The breakup put Amylin on the market for a new partner, and made it a very hot takeover prospect. BMY, AstraZeneca, Merck and Co. Inc., Takeda pharmaceutical Co. Ltd., and Roche AG where among the companies expected to take an interest based on ...
HIV Travel Restrictions In 46 Countries Opposed By Top CEOs At 2012 ...
Other corporations with CEOs participating in the campaign include clothing retailers Nordstrom, Inc.; Gap Inc.; and H&M Hennes & Mauritz AB; drug companies Johnson & Johnson; Bristol-Myers Squibb; Gilead Sciences, Inc.; and Merck & Co.; the Coca-Cola ...